​

Aspire Biopharma Ownership | Who Owns Aspire Biopharma?

OverviewChart

Aspire Biopharma Ownership Summary

Aspire Biopharma is owned by 6.51% institutional investors, 33.08% insiders, and 60.42% retail investors. Crewe advisors is the largest institutional shareholder, holding 1.65% of ASBP shares.

ASBP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAspire Biopharma6.51%33.08%60.42%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Crewe advisors813.43K1.65%$167.57K
Procyon advisors472.66K0.96%$97.37K
Vanguard group428.55K0.87%$88.28K
Optivise advisory services263.52K0.53%$54.29K
Geode capital management250.16K0.51%$51.53K
Antara capital lp202.90K0.41%$41.80K
Vr advisory services97.39K0.20%$20.06K
Resolute advisors82.78K0.17%$17.05K
Three seasons wealth75.00K0.15%$15.45K
P schoenfeld asset management lp58.56K0.12%$12.06K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Antara capital lp202.90K8.53%$41.80K
Optivise advisory services263.52K0.03%$54.29K
Crewe advisors813.43K0.02%$167.57K
Procyon advisors472.66K0.01%$97.37K
Vr advisory services97.39K0.00%$20.06K
Resolute advisors82.78K0.00%$17.05K
Crossingbridge advisors24.35K0.00%$7.42K
Avion wealth54.11K0.00%$11.00K
P schoenfeld asset management lp58.56K0.00%$12.06K
Platform technology partners37.61K0.00%$7.75K

Top Buyers

HolderShares% AssetsChange
Vanguard group428.55K-428.55K
Geode capital management250.16K-250.16K
Antara capital lp202.90K8.53%202.90K
Crewe advisors813.43K0.02%186.57K
Resolute advisors82.78K0.00%82.78K

Top Sellers

HolderShares% AssetsChange
Toronto dominion bank---516.85K
Procyon advisors472.66K0.01%-175.75K
Harraden circle investments---150.00K
Jane street group29.26K--123.30K
Two sigma securities---27.41K

New Positions

HolderShares% AssetsChangeValue
Vanguard group428.55K-428.55K$88.28K
Geode capital management250.16K-250.16K$51.53K
Antara capital lp202.90K8.53%202.90K$41.80K
Resolute advisors82.78K0.00%82.78K$17.05K
P schoenfeld asset management lp58.56K0.00%58.56K$12.06K

Sold Out

HolderChange
Farther finance advisors-20.00
Raymond james financial-2.50K
Scientech research-16.51K
Virtu financial-16.69K
Goldman sachs group-18.70K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20252556.25%3,210,08057.03%60.94%157.14%4-
Jun 30, 202515-2,044,20442.36%267.70%13-13.33%--
Mar 31, 202515-1,435,984-18-15---

Recent Insider Transactions

DateNameRoleActivityValue
Jun 05, 2025Fell Donald G.-Buy$4.09K
Jun 04, 2025Fell Donald G.-Buy$3.71K
Jun 05, 2025Fell Donald G.-Sell$4.09K
Jun 04, 2025Fell Donald G.-Sell$3.71K

Insider Transactions Trends

DateBuySell
2025 Q22-

ASBP Ownership FAQ

Who Owns Aspire Biopharma?

Aspire Biopharma shareholders are primarily institutional investors at 6.51%, followed by 33.08% insiders and 60.41% retail investors. The average institutional ownership in Aspire Biopharma's industry, Biotech Stocks , is 45.24%, which Aspire Biopharma falls below.

Who owns the most shares of Aspire Biopharma?

Aspire Biopharma’s largest shareholders are Crewe advisors (813.43K shares, 1.65%), Procyon advisors (472.66K shares, 0.96%), and Vanguard group (428.55K shares, 0.87%). Together, they hold 3.48% of Aspire Biopharma’s total shares outstanding.

Does Blackrock own Aspire Biopharma?

BlackRock is not among the top 10 institutional shareholders of Aspire Biopharma.

Who is Aspire Biopharma’s biggest shareholder by percentage of total assets invested?

Antara capital lp is Aspire Biopharma’s biggest shareholder by percentage of total assets invested, with 8.53% of its assets in 202.9K Aspire Biopharma shares, valued at 41.8K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools